BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17179230)

  • 21. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel PAX5 rearrangement in TCF3-PBX1 acute lymphoblastic leukemia: a case report.
    Barbosa TC; Lopes BA; Blunck CB; Mansur MB; Deyl AVS; Emerenciano M; Pombo-de-Oliveira MS
    BMC Med Genomics; 2018 Dec; 11(1):122. PubMed ID: 30563523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant-negative mechanism of leukemogenic PAX5 fusions.
    Kawamata N; Pennella MA; Woo JL; Berk AJ; Koeffler HP
    Oncogene; 2012 Feb; 31(8):966-77. PubMed ID: 21765475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13).
    Strehl S; König M; Dworzak MN; Kalwak K; Haas OA
    Leukemia; 2003 Jun; 17(6):1121-3. PubMed ID: 12764378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML.
    Kurahashi S; Hayakawa F; Miyata Y; Yasuda T; Minami Y; Tsuzuki S; Abe A; Naoe T
    Oncogene; 2011 Apr; 30(15):1822-30. PubMed ID: 21217775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
    Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
    Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
    Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
    Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.
    Schinnerl D; Fortschegger K; Kauer M; Marchante JR; Kofler R; Den Boer ML; Strehl S
    Blood; 2015 Feb; 125(8):1282-91. PubMed ID: 25515960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient.
    Kanayama T; Imamura T; Mayumi A; Soma E; Sakamoto K; Hayakawa F; Tanizawa A; Kiyokawa N; Hosoi H
    Int J Hematol; 2020 Nov; 112(5):714-719. PubMed ID: 32656633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21.
    An Q; Wright SL; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Harrison CJ; Strefford JC
    Haematologica; 2009 Aug; 94(8):1164-9. PubMed ID: 19586940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.
    Sakamoto K; Imamura T; Kanayama T; Yano M; Asai D; Deguchi T; Hashii Y; Tanizawa A; Ohshima Y; Kiyokawa N; Horibe K; Sato A
    Genes Chromosomes Cancer; 2017 Apr; 56(4):278-284. PubMed ID: 27870151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
    Kawamata N; Ogawa S; Zimmermann M; Niebuhr B; Stocking C; Sanada M; Hemminki K; Yamatomo G; Nannya Y; Koehler R; Flohr T; Miller CW; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Bartram CR; Koeffler HP
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11921-6. PubMed ID: 18697940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.
    Soler G; Radford-Weiss I; Ben-Abdelali R; Mahlaoui N; Ponceau JF; Macintyre EA; Vekemans M; Bernard OA; Romana SP
    Leukemia; 2008 Jun; 22(6):1278-80. PubMed ID: 18007576
    [No Abstract]   [Full Text] [Related]  

  • 37. Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia.
    Fazio G; Daniele G; Cazzaniga V; Impera L; Severgnini M; Iacobucci I; Galbiati M; Leszl A; Cifola I; De Bellis G; Bresciani P; Martinelli G; Basso G; Biondi A; Storlazzi CT; Cazzaniga G
    Haematologica; 2015 Jan; 100(1):e14-7. PubMed ID: 25304615
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 40. Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression.
    Ray D; Kwon SY; Tagoh H; Heidenreich O; Ptasinska A; Bonifer C
    Blood; 2013 Aug; 122(5):759-69. PubMed ID: 23616623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.